Project

GYDE

GYDE Logo
Keywords

Patient-Centered Therapy Solution for Sexual Distress in Women

Pre Spin-Off

Project Website

For the millions of women in Germany and the EU affected by gynecological conditions, such as endometriosis, breast cancer, gynecological cancers, lichen sclerosus, vulvodynia, or menopause, up to 90 % of them will also then be affected by a secondary condition, sexual distress. This secondary, lifeimpacting condition, while caused by the first cannot be cured by using the same therapies, interventions, or approaches.

Sexual distress has widereaching implications for the women; it takes them out of their society, off family life, and relationships, and often out of work. lt increases the likelihood of pain medication use and depression and is the reason for many healthcare and social costs that could be avoided.

Laura Hatzler
Laura Hatzler
(Charité)

Project Lead

Selina Marie Kronthaler
Selina Marie Kronthaler
(Charité)

Project Lead

There is an evidence-based treatment for sexual distress that should be offered to all of these women but simply isn’t. Only a few physicians will talk about sexual distress with women, even fewer can deliver the therapy. Women are left without guidance or help on how to get to this therapy and their medical costs rise as they search for their answers themselves.

Our clinic at Charité- Universitätskrankenhaus Berlin is one of only 3 in Germany equipped with a team of professionals to deliver sexual distress therapy to women. While we can effectively treat our patients, clinics like ours shockingly see only 1 % of the women who are actually looking for help. That means 99 % of women suffer for a prolonged time and it could be avoided.

We have developed GYDE to take our therapy approach out to the women who don’t find their way to us. We have made our evidence-based therapy digital so it is accessible to women, wherever they are.

GYDE is therapy beyond the clinic and was developed for all women looking for proper medical care for their medical condition. Our first version of GYDE will focus on just one gynecological condition and treatment of the related sexual distress condition: Endometriosis. We will then expand the product to offer therapy to more gynecological conditions and serve the 66 million women looking for help for sexual distress every year in the EU. Our product is designed to be there from the very beginning of the women’s concern through to treatment based on their gynecological treatment and back to a satisfied and fulfilled life.

GYDE is developed by an interdisciplinary team of experts in sexual medicine, gynecology, and psychology. Together, they have many years of experience treating one of the major consequences of gynecological conditions.

DHA

Project Leads